TE_2
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MIRb |
|---|---|
| TE superfamily | L2-end |
| TE order | SINE |
| Gene | WASH9P |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 1.86 |
| Counts of samples | TCGA_tumor:32; TCGA_normal:3; GTEx:16 |
| TSS | chr1(-):195771 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_2.1 | WASH9P | Chimeric | Non-coding | Non-coding | chr1(-):185330,185350,185491,185559,186317,186469,187129,187287,187376,187577,187755,187890,188130,188266,188439,188584,188791,188902,195263,195416,195743,195772 |
| teRNA_2.2 | WASH9P | Chimeric | Non-coding | Non-coding | chr1(-):185330,185350,185491,185559,186317,186469,187129,187287,187376,187577,187755,187890,188130,188266,188439,188584,188791,195416,195743,195772 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
